Katarina Cisarova

Mrs. Katarina Cisarova

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
BRBeryl Royer-Bertrand
Beryl Royer-Bertrand
MTMatteo Torsello
Matteo Torsello
DRDonata Rimoldi
Donata Rimoldi
IZIkram El Zaoui
Ikram El Zaoui
KCKatarina Cisarova
Katarina Cisarova
CRCarlo Rivolta
Carlo Rivolta

1 October 2017 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MQMathieu Quinodoz
Mathieu Quinodoz
BRBeryl Royer-Bertrand
Beryl Royer-Bertrand
KCKatarina Cisarova
Katarina Cisarova
SGSilvio Alessandro Di Gioia
Silvio Alessandro Di Gioia
ASAndrea Superti-Furga
Andrea Superti-Furga
CRCarlo Rivolta
Carlo Rivolta

1 September 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KNKonstantinos Nikopoulos
Konstantinos Nikopoulos
PFPietro Farinelli
Pietro Farinelli
BGBasilio Giangreco
Basilio Giangreco
CTChrysanthi Tsika
Chrysanthi Tsika
BRBeryl Royer-Bertrand
Beryl Royer-Bertrand
CRCarlo Rivolta
Carlo Rivolta

13 February 2023 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
VPVirginie Peter
Virginie Peter
KKKarolina Kaminska
Karolina Kaminska
CSCristina Santos
Cristina Santos
MQMathieu Quinodoz
Mathieu Quinodoz
FCFrancesca Cancellieri
Francesca Cancellieri
CRCarlo Rivolta
Carlo Rivolta
Inherited retinal diseases (IRDs) are a group of ocular conditions characterized by an elevated genetic and clinical heterogeneity. They are transmitted almost invariantly as monogenic traits. However, with more than 280 disease genes identified so far, association of clinical phenotypes with genotypes can be very challenging, and molecular diagnosis is essential for genetic counselling and correct management of the disease. In addition, the prevalence and the assortment of IRD mutations are often population-specific. In this work, we examined 230 families from Portugal, with individuals suffering from a variety of IRD diagnostic classes (270 subjects in total). Overall, we identified 157 unique mutations (34 previously unreported) in 57 distinct genes, with a diagnostic rate of 76%. The IRD mutational landscape was, to some extent, different from those reported in other European populations, including Spanish cohorts. For instance, the EYS gene appeared to be the most frequently mutated, with a prevalence of 10% among all IRD cases. This was, in part, due to the presence of a recurrent, seemingly founder mutation involving the deletion of exons 13 and 14 of this gene. Moreover, our analysis highlighted that as many as 51% of our cases had mutations in a homozygous state. To our knowledge, this is the first study assessing a cross-sectional genotype-phenotype landscape of IRDs in Portugal. Our data reveal a rather unique distribution of mutations, possibly shaped by a small number of rare ancestral events that have now become prevalent alleles in patients.

16 September 2021 in Genes
Verified
Journal Article
Open access
PDF file
BRBeryl Royer
Beryl Royer
KCKatarina Cisarova
Katarina Cisarova
FNFlorence Niel-Butschi
Florence Niel-Butschi
LMLaureane Mittaz-Crettol
Laureane Mittaz-Crettol
HFHeidi Fodstad
Heidi Fodstad
ASAndrea Superti-Furga
Andrea Superti-Furga
To assess the potential of detecting copy number variations (CNVs) directly from exome sequencing (ES) data in diagnostic settings, we developed a CNV-detection pipeline based on ExomeDepth software and applied it to ES data of 450 individuals. Initially, only CNVs affecting genes in the requested diagnostic gene panels were scored and tested against arrayCGH results. Pathogenic CNVs were detected in 18 individuals. Most detected CNVs were larger than 400 kb (11/18), but three individuals had small CNVs impacting one or a few exons only and were thus not detectable by arrayCGH. Conversely, two pathogenic CNVs were initially missed, as they impacted genes not included in the original gene panel analysed, and a third one was missed as it was in a poorly covered region. The overall combined diagnostic rate (SNVs + CNVs) in our cohort was 36%, with wide differences between clinical domains. We conclude that (1) the ES-based CNV pipeline detects efficiently large and small pathogenic CNVs, (2) the detection of CNV relies on uniformity of sequencing and good coverage, and (3) in patients who remain unsolved by the gene panel analysis, CNV analysis should be extended to all captured genes, as diagnostically relevant CNVs may occur everywhere in the genome.

28 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
KNKonstantinos Nikopoulos
Konstantinos Nikopoulos
KCKatarina Cisarova
Katarina Cisarova
MQMathieu Quinodoz
Mathieu Quinodoz
HKHanna Koskiniemi-Kuendig
Hanna Koskiniemi-Kuendig
NMNoriko Miyake
Noriko Miyake
CRCarlo Rivolta
Carlo Rivolta
Hereditary retinal degenerations (HRDs) are Mendelian diseases characterized by progressive blindness and caused by ultra-rare mutations. In a genomic screen of 331 unrelated Japanese patients, we identify a disruptive Alu insertion and a nonsense variant (p.Arg1933*) in the ciliary gene RP1, neither of which are rare alleles in Japan. p.Arg1933* is almost polymorphic (frequency = 0.6%, amongst 12,000 individuals), does not cause disease in homozygosis or heterozygosis, and yet is significantly enriched in HRD patients (frequency = 2.1%, i.e., a 3.5-fold enrichment; p-value = 9.2 × 10−5). Familial co-segregation and association analyses show that p.Arg1933* can act as a Mendelian mutation in trans with the Alu insertion, but might also associate with disease in combination with two alleles in the EYS gene in a non-Mendelian pattern of heredity. Our results suggest that rare conditions such as HRDs can be paradoxically determined by relatively common variants, following a quasi-Mendelian model linking monogenic and complex inheritance.